Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy

References

• Batrakova EV, Kabanov AV. (2008). Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 130:98–106.
   PubMed Web of Science ®Google Scholar
• Bocchi EA, Bacal F, Auler Junior JO, et al. (1994). Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol 74:70–2.
   PubMed Web of Science ®Google Scholar
• Bruch C, Schmermund A, Marin D, et al. (2000). Tei-index in patients with mild-to-moderate congestive heart failure. Eur Heart J 21:1888–95.
   PubMed Web of Science ®Google Scholar
• Buondonno I, Gazzano E, Jean SR, et al. (2016). Mitochondria-targeted doxorubicin: a new therapeutic strategy against doxorubicin-resistant osteosarcoma. Mol Cancer Ther 15:2640–52.
   PubMed Web of Science ®Google Scholar
• Burridge PW, Li YF, Matsa E, et al. (2016). Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med 22:547–56.
   PubMed Web of Science ®Google Scholar
• Chen JR, Wei J, Wang LY, et al. (2015). Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill(R) via ameliorate of multiple mitochondrial dysfunctions. Drug Des Devel Ther 9:3051–66.
   PubMed Web of Science ®Google Scholar
• Chen Y, Sha X, Zhang W, et al. (2013). Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation. Int J Nanomedicine 8:1463–76.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang L, Li Y. (2014). Addition of pluronics(R) to reducible disulfide-bond-containing pluronic(R)-PEI-SS specifically enhances circulation time in vivo and transfection efficiency in vitro. J Biomed Mater Res B Res 102:1268–76.
   PubMed Web of Science ®Google Scholar
• Cheng L, Sun X, Hu C, et al. (2014). In vivo early intervention and the therapeutic effects of 20(s)-ginsenoside rg3 on hypertrophic scar formation. PLoS One 9:e113640.
   PubMed Web of Science ®Google Scholar
• Cheng L, Sun X, Hu C, et al. (2013a). In vivo inhibition of hypertrophic scars by implantable ginsenoside-Rg3-loaded electrospun fibrous membranes. Acta Biomater 9:9461–73.
   PubMed Web of Science ®Google Scholar
• Cheng L, Sun X, Li B, et al. (2013b). Electrospun Ginsenoside Rg3/poly(lactic-co-glycolic acid) fibers coated with hyaluronic acid for repairing and inhibiting hypertrophic scars. J Mater Chem B 1:4428.
   PubMed Web of Science ®Google Scholar
• Cheng L, Sun X, Zhao X, et al. (2016a). Surface biofunctional drug-loaded electrospun fibrous scaffolds for comprehensive repairing hypertrophic scars. Biomaterials 83:169–81.
   PubMed Web of Science ®Google Scholar
• Cheng T, Liu J, Ren J, et al. (2016b). Green tea catechin-based complex micelles combined with doxorubicin to overcome cardiotoxicity and multidrug resistance. Theranostics 6:1277–92.
   PubMed Web of Science ®Google Scholar
• Chu M, Li H, Wu Q, et al. (2014). Pluronic-encapsulated natural chlorophyll nanocomposites for in vivo cancer imaging and photothermal/photodynamic therapies. Biomaterials 35:8357–73.
   PubMed Web of Science ®Google Scholar
• Cote B, Carlson LJ, Rao DA, Alani AW. (2015). Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo. J Control Release 213:128–33.
   PubMed Web of Science ®Google Scholar
• El-Ashmawy NE, Khedr EG, Ebeid EM, et al. (2017). Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma. Eur J Pharm Sci 109:525–32.
   PubMed Web of Science ®Google Scholar
• Giordano SH, Lin YL, Kuo YF, et al. (2012). Decline in the use of anthracyclines for breast cancer. J Clin Oncol 30:2232–9.
   PubMed Web of Science ®Google Scholar
• Hao P, Jiang F, Cheng J, et al. (2017). Traditional Chinese Medicine for cardiovascular disease: evidence and potential mechanisms. J Am Coll Cardiol 69:2952–66.
   PubMed Web of Science ®Google Scholar
• Hollman PC, Van Trijp JM, Buysman MN, et al. (1997). Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 418:152–6.
   PubMed Web of Science ®Google Scholar
• Hou J, Wang J, Sun E, et al. (2016). Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers. Drug Deliv 23:3248–56.
   PubMed Web of Science ®Google Scholar
• Ichikawa Y, Ghanefar M, Bayeva M, et al. (2014). Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest 124:617–30.
   PubMed Web of Science ®Google Scholar
• Khiati S, Dalla Rosa I, Sourbier C, et al. (2014). Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity. Clin Cancer Res 20:4873–81.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Jang JY, Kim EJ, et al. (2017). Ginsenoside Rg3 restores hepatitis C virus-induced aberrant mitochondrial dynamics and inhibits virus propagation. Hepatology 66:758–71.
   Google Scholar
• Kirshenbaum LA, Singal PK. (1992). Antioxidant changes in heart hypertrophy: significance during hypoxia-reoxygenation injury. Can J Physiol Pharmacol 70:1330–5.
   PubMed Web of Science ®Google Scholar
• Lipshultz SE, Franco VI, Miller TL, et al. (2015). Cardiovascular disease in adult survivors of childhood cancer. Annu Rev Med 66:161–76.
   PubMed Web of Science ®Google Scholar
• Liu QY, Zhang ZH, Jin X, et al. (2013). Enhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosan. J Pharm Pharmacol 65:839–46.
   PubMed Web of Science ®Google Scholar
• Luo YY, Xiong XY, Tian Y, et al. (2016). A review of biodegradable polymeric systems for oral insulin delivery. Drug Deliv 23:1882–91.
   PubMed Web of Science ®Google Scholar
• Meng X, Liu J, Yu X, et al. (2017). Pluronic F127 and D-alpha-tocopheryl polyethylene glycol succinate (TPGS) mixed micelles for targeting drug delivery across the blood brain barrier. Sci Rep 7:2964.
   PubMed Web of Science ®Google Scholar
• Monteiro JP, Oliveira PJ, Jurado AS. (2013). Mitochondrial membrane lipid remodeling in pathophysiology: a new target for diet and therapeutic interventions. Prog Lipid Res 52:513–28.
   PubMed Web of Science ®Google Scholar
• Octavia Y, Tocchetti CG, Gabrielson KL, et al. (2012). Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52:1213–25.
   PubMed Web of Science ®Google Scholar
• Oerlemans C, Bult W, Bos M, et al. (2010). Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res 27:2569–89.
   PubMed Web of Science ®Google Scholar
• Peters AA, Milevskiy MJ, Lee WC, et al. (2016). The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin. Sci Rep 6:25505.
   PubMed Web of Science ®Google Scholar
• Rogers GW, Brand MD, Petrosyan S, et al. (2011). High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS One 6:e21746.
   PubMed Web of Science ®Google Scholar
• Sarisozen C, Vural I, Levchenko T, et al. (2012). Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance. Drug Deliv 19:363–70.
   PubMed Web of Science ®Google Scholar
• Scott JM, Khakoo A, Mackey JR, et al. (2011). Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms. Circulation 124:642–50.
   PubMed Web of Science ®Google Scholar
• Sleijfer S, Van Der Gaast A, Planting AS, et al. (2005). The potential of statins as part of anti-cancer treatment. Eur J Cancer 41:516–22.
   PubMed Web of Science ®Google Scholar
• Smith I, Williamson EM, Putnam S, et al. (2014). Effects and mechanisms of ginseng and ginsenosides on cognition. Nutr Rev 72:319–33.
   PubMed Web of Science ®Google Scholar
• Sonali Agrawal P, Singh RP, Rajesh CV, et al. (2016). Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Deliv 23:1788–98.
   PubMed Web of Science ®Google Scholar
• Sun X, Cheng L, Zhu W, et al. (2014). Use of ginsenoside Rg3-loaded electrospun PLGA fibrous membranes as wound cover induces healing and inhibits hypertrophic scar formation of the skin. Colloids Surf B Biointerfaces 115:61–70.
   PubMed Web of Science ®Google Scholar
• Tang C, Ye Y, Feng Y, Quinn RJ. (2016). TCM, brain function and drug space. Nat Prod Rep 33:6–25.
   PubMed Web of Science ®Google Scholar
• Thollon C, Iliou JP, Cambarrat C, et al. (1995). Nature of the cardiomyocyte injury induced by lipid hydroperoxides. Cardiovasc Res 30:648–55.
   PubMed Web of Science ®Google Scholar
• Walker JR, Sharma A, Lytwyn M, et al. (2011). The cardioprotective role of probucol against anthracycline and trastuzumab-mediated cardiotoxicity. J Am Soc Echocardiogr 24:699–705.
   PubMed Web of Science ®Google Scholar
• Walle T. (2011). Bioavailability of resveratrol. Ann NY Acad Sci 1215:9–15.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen L, Wang T, et al. (2015a). Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt. Phytomedicine 22:875–84.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen Y, Wang H, et al. (2015b). Specific turn-on fluorescent probe with aggregation-induced emission characteristics for SIRT1 modulator screening and living-cell imaging. Anal Chem 87:5046–9.
   PubMed Web of Science ®Google Scholar
• Xu W, Cui Y, Ling P, Li LB. (2012). Preparation and evaluation of folate-modified cationic pluronic micelles for poorly soluble anticancer drug. Drug Deliv 19:208–19.
   PubMed Web of Science ®Google Scholar
• Yang LQ, Wang B, Gan H, et al. (2012). Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo. Biopharm Drug Dispos 33:425–36.
   PubMed Web of Science ®Google Scholar
• Yokoyama M. (2005). Drug targeting with nano-sized carrier systems. J Artif Organs 8:77–84.
   PubMedGoogle Scholar
• Zhang S, Liu X, Bawa-Khalfe T, et al. (2012). Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 18:1639–42.
   PubMed Web of Science ®Google Scholar
• Zhao P, Wu S, Cheng Y, et al. (2017). MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma. Nanomedicine S1549–9634:30096–5.
   Google Scholar
• Zhou B, Yan Z, Liu R, et al. (2016). Prospective study of transcatheter arterial chemoembolization (TACE) with ginsenoside Rg3 versus TACE alone for the treatment of patients with advanced hepatocellular carcinoma. Radiology 280:630–9.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Guo T, Xia D, et al. (2013). Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration. J Pharm Pharmacol 65:1107–17.
   PubMed Web of Science ®Google Scholar